CLASS II Drug recall · Reported 2 May 2018 · FDA Enforcement Report

Ibuprofen Caplets USP 200 mg, a) 50 caplets recalled

Time-Cap Laboratories is recalling Ibuprofen Caplets USP 200 mg, a) 50 caplets (, distributed nationwide in the US. The recall was initiated on 11 Jan 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesa) F066C b) F066C c) F066C
NDC49483-114, 49483-601, 49483-600
UPC0349483600018, 0349483601015, 0349483600056, 0349483114171, 0349483600506
Quantity recalledN/A

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0694-2018
FDA event ID
79349
Recalling firm
Time-Cap Laboratories, Farmingdale, NY
Manufacturer
TIME CAP LABORATORIES,INC
Classification
Class II
Status
Terminated
Recall initiated
11 Jan 2018
FDA classified
22 Apr 2018
Reported
2 May 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Drug class
Pain Medication

Timeline

11 Jan 2018Recall initiated by company
22 Apr 2018Classified by FDA+101 days
2 May 2018Published in enforcement report+10 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Product as listed by the FDA

Ibuprofen Caplets USP 200 mg, a) 50 caplets (NDC 49483-600-05), b) 100 caplets (NDC 49483-600-01), c) 500 caplets (NDC 49483-600-50), and d) BULK (NDC 49483-600-00) bottles, Rx, Manufactured for: Time Cap labs, Inc., Farmingdale, NY 11735, Manufactured by: Marksans Pharma, Ltd., Verna, Goa-403 722, India

Where it was distributed

Nationwide.

Nationwide

Questions about this recall

Is Ibuprofen Caplets USP 200 mg, a) 50 caplets ( recalled?

Yes. Time-Cap Laboratories recalled Ibuprofen Caplets USP 200 mg, a) 50 caplets ( on 11 Jan 2018. The recall is Class II and its status is Terminated. Recall number D-0694-2018.

Why was it recalled?

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Which lots are affected?

a) F066C b) F066C c) F066C

Where was it sold?

Nationwide.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Time-Cap Laboratories

All 12

Other Ibuprofen recalls

All 38